John Mao Selected Research

VNP 20009 (VNP20009)

7/2002	Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.
1/2002	Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Mao Research Topics

Disease

3	Neoplasms (Cancer) 07/2002 - 01/2002
2	Infections 11/2022 - 01/2022
2	Dizziness (Lightheadedness) 01/2022 - 09/2012
2	Nausea 01/2022 - 01/2002
2	Diarrhea 11/2006 - 01/2002
1	Disease Progression 05/2024
1	COVID-19 05/2024
1	Chronic Hepatitis B 11/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2012
1	Fatigue 09/2012
1	Chronic Hepatitis C 11/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2002
1	Anemia 01/2002
1	Hyperbilirubinemia 01/2002
1	Hypophosphatemia 01/2002
1	Melanoma (Melanoma, Malignant) 01/2002
1	Thrombocytopenia (Thrombopenia) 01/2002
1	Vomiting 01/2002
1	Bacteremia 01/2002

Drug/Important Bio-Agent (IBA)

2	GST-HG131IBA 11/2022 - 01/2022
2	VNP 20009 (VNP20009)IBA 07/2002 - 01/2002
1	Ritonavir (Norvir)FDA Link 05/2024
1	TabletsIBA 05/2024
1	AntigensIBA 11/2022
1	AndrogensIBA 01/2020
1	Mesylates (Mesylate)IBA 01/2020
1	SuspensionsIBA 01/2020
1	Leuprolide (Lupron)FDA LinkGeneric 01/2020
1	TroponinIBA 09/2012
1	CK-2017357IBA 09/2012
1	2'-C-methylcytidineIBA 11/2006
1	Cytosine DeaminaseIBA 07/2002
1	Fluorouracil (Carac)FDA LinkGeneric 07/2002
1	ProdrugsIBA 07/2002
1	EnzymesIBA 07/2002
1	Antineoplastic Agents (Antineoplastics)IBA 07/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	Alkylating AgentsIBA 01/2002
1	laromustine (VNP40101M)IBA 01/2002
1	Alkaline PhosphataseIBA 01/2002
1	hydrazine (hydrazine dihydrochloride)IBA 01/2002

Therapy/Procedure

2	Intravenous Administration 07/2002 - 01/2002
1	Injections 01/2020
1	Subcutaneous Injections 01/2020
1	Therapeutics 01/2020
1	Intravenous Infusions 01/2002